EPIB301: Exam 2 Prep

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/86

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:22 PM on 4/7/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

87 Terms

1
New cards

What are the characteristics of experimental studies?

Manipulations of variables; assigning participants to exposure group, only use when feasible and ethical

2
New cards

What are the examples of experimental studies?

Quasi-Experimental and Randomized Control trial (RCT)

3
New cards

What are the characteristics of observational studies?

Investigator watches, and there is no manipulation or exposure. Used when an experimental study is not feasible

4
New cards

What are the examples of observational studies?

Cohort, case control, and cross-sectional

5
New cards

What are the types of intervention designs?

Clinical trials and community trials

6
New cards

What is the focus of clinical trials?

Individuals

7
New cards

What is the focus of community trials?

Group or community

8
New cards

What is a community trial (community intervention)?

Intervention that is allocated to entire communities

9
New cards

What are the characteristics of randomization (Randomized Control Trial/RCT)?

  • Each participant has the same probability of being put into the treatment group

  • Eliminate bias in treatment assignment

  • Confounding factors will be balanced between the treatment and control groups, making these groups directly comparable

10
New cards

What is the ultimate goal of randomization (RCT)?

Ensure comparability between study groups by balancing known and unknown confounding factors

11
New cards

What does binding/masking mean?

Participants and/or researchers are unaware which subjects is getting the treatmment or placebo

12
New cards

What are the phases of a clinical trial summarized?

Start with small and specific samples, then gradually grow larger and broader. Continue monitoring after FDA approval

13
New cards

What is phase 1 of clinical trials?

Tests drug on healthy individuals, tests for safety dosage and side effects

14
New cards

What is phase 2 of clincal trials?

Tests on larger group of effected individuals, tests for efficacy and side effects

15
New cards

What is phase 3 of clinical trials?

Tests on new and wider demographic, tests for long term effectiveness and comparisons with other medications

16
New cards

What is the FDA approval phase of clinical trials?

Treatment determined effective and safe for public use

17
New cards

What is phase 4 of clinical trials?

Continues to test for effectiveness and safety, can be taken off the market if necessary

18
New cards

What is similar to clinical trials?

Cohort studies

19
New cards

What is the formula of RR (Relative risk)?

A/(A+B) divided by C/(C+D)

20
New cards

If RR = 1, what does that indicate?

no association

21
New cards

If RR > 1, what does that indicate?

treatment group more likely to develop the outcome

22
New cards

If RR < 1, what does that indicate?

treatment group less likely to develop outcome

23
New cards

If the outcome is improvement, a RR > 1 would mean what?

Treatment group is more likely to improve;

24
New cards

If the outcome is improvement, a RR < 1 would mean what?

treatment group is less likely to improve

25
New cards

What is efficacy in terms of epidemiology?

The proportion of individuals in the control group who experience an unfavorable outcome who could have been expected to have a favorable outcome had they been in the active group instead

26
New cards

What indicates that an intervention was successful: Low efficacy or high efficacy?

High efficacy

27
New cards

What does NNT stand for?

Number Needed to Treat

28
New cards

What does NNT mean?

The expected number of people who would have received a treatment to prevent an unfavorable outcome in one person

29
New cards

What indicates a more effective intervention: a small NNT or a big NNT?

Small NNT

30
New cards
  • A participant is given a “fake” intervention.

  • Participant believes this intervention will change or improve his/her condition.

  • This belief can have a therapeutic effect.

  • Sometimes this belief improves their condition in a measurable way

What is this phenomenon known as?

Placebo effect

31
New cards

Why do experimental studies involve a high level of ethical risk?

Participants do not choose whether they get assigned to exposures (treatments)

32
New cards

What is the list of ethical considerations for experimental studies?

  • Informed consent (plan language, multiple languages)

  • Withholding treatment known to be effective

  • Protecting the interests of the individual patient

  • Monitoring for side effects

  • Deciding when to withdraw a patient

33
New cards

What are these the strengths of?

  • Provides the strongest evidence of association

  • Manipulation means having control over:

    • Amount of exposure

    • Timing and requency of exposure

    • Period of observation

  • Ability to randomize reduces the likelihood that group will differ significantly

Experimental designs

34
New cards

What are these the strengths of?

  • They represent the only way to estimate the impact of change in behavior or modifiable exposure on the incidence of disease.

  • Manipulation of intervention and period of observation

  • Ability to randomize at community level

Community trials

35
New cards

What are these the limitations of?

  • They are inferior to clinical trials with respect to the ability to control entrance into the study, delivery of the intervention, and monitoring of outcomes

  • Fewer study units are capable of being randomized, which affects comparability

  • They are affected by population dynamics, secular trends, and nonintervention influences

Community trials

36
New cards

What are these the limitations of?

  • Artificial setting

  • Limited scope of potential impact

  • Adherence to protocol is difficult to enforce

  • Expensive

  • Ethical concerns

Experimental designs

37
New cards

Name this study design:

To test the efficacy of vitamin C in preventing colds, army recruits are randomly assigned to two groups: one given 500 mg of vitamin C daily, and one given a placebo. Both groups are followed to determine the number and severity of subsequent colds.

Randomized control trial

38
New cards
<p>What is A?</p>

What is A?

Ecological Study

39
New cards
<p>What is B?</p>

What is B?

Randomized Controlled Trial

40
New cards
<p>What is C?</p>

What is C?

Quasi-experimental Study

41
New cards
<p>What is D?</p>

What is D?

Case-Control Study

42
New cards
<p>What is E?</p>

What is E?

Prospective Cohort Study

43
New cards
<p>What is F?</p>

What is F?

Restrospective Cohort Study

44
New cards
<p>What is G?</p>

What is G?

Cross-Sectional Study

45
New cards
<p>What is A?</p>

What is A?

Community trials

46
New cards
<p>What is B?</p>

What is B?

Clinical Trials/RCTS

47
New cards
<p>What is C?</p>

What is C?

Ecological Studies

48
New cards
<p>What is D?</p>

What is D?

Cross-sectional Studies

49
New cards
<p>What is E?</p>

What is E?

Case Reports & Case Series

50
New cards
<p>What is F?</p>

What is F?

Case Cohort Studies

51
New cards
<p>What is G?</p>

What is G?

Cohort Studies

52
New cards

What fits experimental trials but not a prospective cohort study?

Exposure status is assigned by the researcher(s) into treatment and control groups (experimental)

53
New cards

What is the similary between experimental trials and prospective cohort study?

Outcome has not yet occured at the start of the study for any of the participants

54
New cards

What is the similarity between a prospective cohort study and a retrospective cohort study?

Participants selected based on exposure status/shared characteristics known as cohort (other than outcome)

55
New cards

What is the similarty between restrospective cohort study and case-control study?

Outcome status of participants is known at the start of the study

56
New cards

What fits case-control study but not a retrospective cohort study?

Participants selected based on outcome/disease status

57
New cards

What is a prospective cohort study?

A study of healthy participants who are followed forward in time to observe the development of an outcome

58
New cards

What is a retrospective cohort study?

Uses historical records or recall to determine exposure status at a specific point in the past, assess the already existing outcome

59
New cards

What are these the strengths of?

  • Collect information on multiple exposures and outcomes

  • Efficient for rare exposures

  • Temporality

Prospective Cohort Study

60
New cards

What are these the strengths of?

  • Efficient for disease with long latency periods

  • Temporality (when using good historical records, not guaranteed)

  • Low cost and quick

Retrospective Cohort Study

61
New cards

What are these the limitations of?

  • Expensive and time-consuming

  • Not practical for diseases with long latent periods

Prospective Cohort Study

62
New cards

What are these the limitations of?

  • May have poor information on exposures or other key variables

  • Only as good as the data (records) available

Retrospective Cohort Study

63
New cards
<p>What is this formula for?</p>

What is this formula for?

Relative Risk (RR)

64
New cards
<p>What is this formula for?</p>

What is this formula for?

Risk Difference (Attributable risk)

65
New cards
<p>In the equation given, what does A/(A+B) mean?</p>

In the equation given, what does A/(A+B) mean?

Risk exposed

66
New cards
<p>In the equation given, what does C/(C+D) mean?</p>

In the equation given, what does C/(C+D) mean?

Risk unexposed

67
New cards

What is the interpretation of relative risk > 1?

The risk of [outcome] in the [exposed group] is [RR] times higher than in the [unexposed group].

68
New cards

What is the interpretation of relative risk = 1?

The risk of [outcome] in the [exposed group] is the same as the risk of [outcome] in the [unexposed].

69
New cards

What is the interpretation of relative risk < 1?

The risk of [outcome] in the [exposed group] is [(1-RR)x100%] lower than in the [unexposed group].

70
New cards

What is the interpretation of risk difference?

[The exposed group] had [value] times higher risk of developing [outcome] compared to [the unexposed group].

71
New cards

What are these the strengths of?

  • Efficient for rare diseases and diseases with long induction or latent periods

  • Can evaluate multiple risk factors for the same disease so useful for poorly understood diseases

  • Typically inexpensive because they use a smaller number of subjects

Case-control Study

72
New cards

What are these the limitations of?

  • Inefficient for rare exposures

  • Vulnerable to recall bias because of the retrospective nature

  • Can only study one outcome

Case-control Study

73
New cards

What is odds ratio?

Odds of exposure among cases divided by the odds of exposure among controls

74
New cards

What is odds ratio used for?

Case-control Study

75
New cards
<p>What is this equation?</p>

What is this equation?

Odds ratio

76
New cards

What is the interpretation of the odds ratio?

The odds of [exposure] among the [cases] is [#] times that of the [controls].

77
New cards

What are these the strengths of?

  • Measures prevalence (disease frequency)

  • Single point in time, so investigators do not have to follow up with individuals over time

  • Useful for establishing preliminary evidence for future planning of studies

  • Population-based so it helps investigators understand determinants of health

Cross-sectional Study

78
New cards

What are these the limitations of?

  • Cannot follow up or establish a causal relationship

    • Only 1 time measurement of exposure and no follow-up

  • Prone to bias

  • Selection bias: when study participants’ characteristics are systematically different compared to eligible participants not selected for the study

Cross-sectional Study

79
New cards

What are these the strengths of?

  • Low cost (typically using data that was already collected)

  • Useful to examine the rate of disease in relation to a population-level factor

Ecological Study

80
New cards

What are these the limitations of?

  • Ecological fallacy

Ecological Study

81
New cards

What is an ecological fallacy?

Drawing conclusions about indivduals based on data collected at the GROUP level

82
New cards

What is this an example of?

A specific neighborhood has a high crime rate, assume that a resident living in that area is more likely to commit a crime.

Ecological fallacy

83
New cards

What is this an example of?

Richer cities have higher rates of heart disease, assume that richer individuals have higher rates of heart disease than poorer individuals.

Ecological fallacy

84
New cards

Which of the following represents the main strength of case-control studies?

Efficiency

85
New cards

What is the study design?

In order to determine if vitamin D (the “sunshine” vitamin) is associated with reduced levels of ovarian cancer, an epidemiologist identified 12 geographic regions in Sweden and obtained data on the average annual number of days of sunlight and ovarian cancer rates for each region. The findings indicated that those regions with the highest average days of sunlight per year had significantly lower rates of ovarian cancer than those regions with the fewest average days of sunlight per year. The epidemiologist reported her findings at the Scandinavian Conference on Cancer.

Ecological Study

86
New cards

What is this study design?

Smoking histories are obtained from all patients entering a hospital who have lip cancer and are compared with smoking histories of other patients who enter the same hospital.

Case control Study

87
New cards

What is this study design?